General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin D

被引:52
|
作者
Sempos, Christopher T. [1 ]
Betz, Joseph M. [1 ]
Camara, Johanna E. [2 ]
Carter, Graham D. [3 ]
Cavalier, Etienne [4 ]
Clarke, Michael W. [5 ]
Dowling, Kirsten G. [6 ]
Durazo-Arvizu, Ramon A. [7 ]
Hoofnagle, Andrew N. [8 ]
Liu, Andy [9 ]
Phinney, Karen W. [10 ]
Sarafin, Kurtis [11 ]
Wise, Stephen A. [1 ,2 ]
Coates, Paul M. [1 ]
机构
[1] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA
[2] NIST, Chem Sci Div, Gaithersburg, MD 20899 USA
[3] Imperial Coll Healthcare NHS Trust, London, England
[4] Univ Liege, CHU Liege, Dept Clin Chem, Liege, Belgium
[5] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia
[6] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin & Nutr Res D, Cork, Ireland
[7] Loyola Univ Chicago, Dept Publ Hlth Sci, Chicago, IL USA
[8] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[9] Son Healthcare, Douglass Hanly Moir Pathol, Sydney, NSW, Australia
[10] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA
[11] Hlth Canada, Nutr Res Div, Ottawa, ON, Canada
关键词
TANDEM MASS-SPECTROMETRY; VITAMIN-D METABOLITES; D-3;
D O I
10.5740/jaoacint.17-0259
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The Vitamin D Standardization Program (VDSP) has collaborated with numerous groups and agencies to assemble a set of tools, i.e., a reference measurement system, that can be used to establish the traceability of 25-hydroxyvitamin D [25(OH)D] assays to relevant reference measurement procedures and reference materials. This is done with the goal of verifying end-user laboratory performance using precise statistical criteria to determine whether a specific assay is standardized. The purpose of this paper was to outline a set of steps that routine clinical and research laboratories can use to standardize their 25(OH)D assays using these tools. These steps apply to laboratories using commercially developed immunoassay measurement systems as well as in-house assays, usually based on high HPLC or LC tandem MS measurement systems. The steps are (1) initial calibration, (2) initial assessment of accuracy and bias, (3) assessment of total percent CV and mean bias, (4) use of trueness controls, and (5) participation in accuracy-based performance testing and/or external quality assessment schemes. The goal of each laboratory assay is to have a total CV of <= 10% and mean bias of 55%. Rigorous and less rigorous but low-cost options for meeting these statistical criteria are provided. Research laboratories who infrequently measure 25(OH)D are advised to repeat steps 1-4 for every measurement cycle. For users of commercial immunoassays who have relatively little control over standardization, we present an option for using trueness controls to develop a master equation that can be used to standardize results to the reference methods.
引用
收藏
页码:1230 / 1233
页数:4
相关论文
共 50 条
  • [21] TREATMENT WITH 50 000 IU VITAMIN D2 EVERY OTHER WEEK AND EFFECT ON SERUM 25-HYDROXYVITAMIN D2, 25-HYDROXYVITAMIN D3, AND TOTAL 25-HYDROXYVITAMIN D IN A CLINICAL SETTING
    Demetriou, Emily T. W.
    Travison, Thomas G.
    Holick, Michael F.
    ENDOCRINE PRACTICE, 2012, 18 (03) : 399 - 402
  • [22] Laboratory confirmation of the effect of occupational sun exposure on serum 25-hydroxyvitamin D concentration
    Lee, Dong-Hyun
    Park, Ki Soo
    Cho, Min-Chul
    MEDICINE, 2018, 97 (27)
  • [23] Serum 25-hydroxyvitamin D and functional outcomes in the elderly
    Dawson-Hughes, Bess
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (02): : 537S - 540S
  • [24] Serum 25-Hydroxyvitamin D Concentration and Risk of Dementia
    Knekt, Paul
    Saaksjarvi, Katri
    Jarvinen, Ritva
    Marniemi, Jukka
    Mannisto, Satu
    Kanerva, Noora
    Heliovaara, Markku
    EPIDEMIOLOGY, 2014, 25 (06) : 799 - 804
  • [25] Serum 25-hydroxyvitamin D levels and atopic diseases
    Ginaldi, L.
    Ciccarelli, F.
    Nocelli, C.
    de Martinis, M.
    ALLERGY, 2013, 68 : 344 - 344
  • [26] Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay
    Turpeinen, U
    Hohenthal, U
    Stenman, UH
    CLINICAL CHEMISTRY, 2003, 49 (09) : 1521 - 1524
  • [27] Serum 25-hydroxyvitamin D and the risk of ovarian cancer
    Toriola, Adetunji T.
    Surcel, Helja-Marja
    Agborsangaya, Calypse
    Grankvist, Kjell
    Tuohimaa, Pentti
    Toniolo, Paolo
    Lukanova, Annekatrin
    Pukkala, Eero
    Lehtinen, Matti
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) : 364 - 369
  • [28] An International Comparison of Serum 25-Hydroxyvitamin D Measurements
    P. Lips
    M. C. Chapuy
    B. Dawson-Hughes
    H. A. P. Pols
    M. F. Holick
    Osteoporosis International, 1999, 9 : 394 - 397
  • [29] Serum 25-Hydroxyvitamin D Concentration and Cognitive Impairment
    Llewellyn, David J.
    Langa, Kenneth M.
    Lang, Iain A.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2009, 22 (03) : 188 - 195
  • [30] Measurement of 25-hydroxyvitamin D in the clinical laboratory: Current procedures, performance characteristics and limitations
    Wallace, A. M.
    Gibson, S.
    de la Hunty, A.
    Lamberg-Allardt, C.
    Ashwell, M.
    STEROIDS, 2010, 75 (07) : 477 - 488